US4309095A
(en)
|
1980-11-03 |
1982-01-05 |
Buckley Frederick P |
Camera mounting device
|
US4356170A
(en)
|
1981-05-27 |
1982-10-26 |
Canadian Patents & Development Ltd. |
Immunogenic polysaccharide-protein conjugates
|
US4673574A
(en)
|
1981-08-31 |
1987-06-16 |
Anderson Porter W |
Immunogenic conjugates
|
US4459286A
(en)
|
1983-01-31 |
1984-07-10 |
Merck & Co., Inc. |
Coupled H. influenzae type B vaccine
|
US4663160A
(en)
|
1983-03-14 |
1987-05-05 |
Miles Laboratories, Inc. |
Vaccines for gram-negative bacteria
|
US4761283A
(en)
|
1983-07-05 |
1988-08-02 |
The University Of Rochester |
Immunogenic conjugates
|
US4808700A
(en)
|
1984-07-09 |
1989-02-28 |
Praxis Biologics, Inc. |
Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
|
EP0273116A3
(en)
|
1986-10-09 |
1990-05-02 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Gonococcal and meningococcal polypeptides, vaccines and diagnostics
|
NO882936D0
(no)
*
|
1987-07-07 |
1988-07-01 |
Nl Mini Welzijn Gesund Cultur |
Flerverdig meningokokkvaksine.
|
RU2023448C1
(ru)
|
1987-07-30 |
1994-11-30 |
Сентро Насьональ Де Биопрепарадос |
Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в
|
US4835621A
(en)
|
1987-11-04 |
1989-05-30 |
Black John W |
Gun mounted video camera
|
NL8802046A
(nl)
|
1988-08-18 |
1990-03-16 |
Gen Electric |
Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen.
|
EP0449958B9
(en)
|
1988-12-19 |
2003-05-28 |
American Cyanamid Company |
Meningococcal class 1 outer-membrane protein vaccine
|
NL8803111A
(nl)
|
1988-12-19 |
1990-07-16 |
Nederlanden Staat |
Multivalent meningococcen klasse i buitenmembraaneiwit vaccin.
|
DK130889A
(da)
|
1989-03-17 |
1990-09-18 |
Mogens Kilian |
Immunoglobulin a1-proteaser (iga1-proteaser), fremgangsmaade til genteknologisk fremstilling af saadanne enzymer samt vaccine indeholdende enzymerne og fragmenter deraf til immunisering mod bakteriel meningitis og andre sygdomme fremkaldt af iga1-protease-producerende bakterier
|
EP0467714A1
(en)
|
1990-07-19 |
1992-01-22 |
Merck & Co. Inc. |
The class II protein of the outer membrane of neisseria meningitidis
|
US5020262A
(en)
|
1990-09-04 |
1991-06-04 |
Pena Louis T |
Camera mount for rifle scopes
|
ES2127217T3
(es)
|
1991-03-14 |
1999-04-16 |
Imclone Systems Inc |
Epitopos de porina hibridos de recombinacion.
|
FR2692592B1
(fr)
|
1992-06-19 |
1995-03-31 |
Pasteur Merieux Serums Vacc |
Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
|
NL9201716A
(nl)
|
1992-10-02 |
1994-05-02 |
Nederlanden Staat |
Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat.
|
US5439808A
(en)
|
1993-07-23 |
1995-08-08 |
North American Vaccine, Inc. |
Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
|
FR2720408B1
(fr)
|
1994-05-31 |
1996-08-14 |
Pasteur Merieux Serums Vacc |
Fragments Tbp2 de Neisseria meningitidis.
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
US6180111B1
(en)
|
1995-05-18 |
2001-01-30 |
University Of Maryland |
Vaccine delivery system
|
FR2739624B1
(fr)
|
1995-10-10 |
1997-12-05 |
Pasteur Merieux Serums Vacc |
Nouvelle sous-unite tbp2 de neisseria meningitidis
|
JP4162267B2
(ja)
|
1996-08-27 |
2008-10-08 |
カイロン コーポレイション |
Neisseria meningitidis血清型B複合糖質およびその使用法
|
US6472518B1
(en)
|
1996-10-24 |
2002-10-29 |
Centers For Disease Control And Prevention, As Represented By The Secretary, Department Of Health And Human Services |
Invasion associated genes from Neisseria meningitidis serogroup B
|
GB9711964D0
(en)
|
1997-06-09 |
1997-08-06 |
Medical Res Council |
Live attenuated vaccines
|
EP1900818A3
(en)
|
1997-11-06 |
2008-06-11 |
Novartis Vaccines and Diagnostics S.r.l. |
Neisserial antigens
|
US6914131B1
(en)
*
|
1998-10-09 |
2005-07-05 |
Chiron S.R.L. |
Neisserial antigens
|
US5887375A
(en)
|
1997-11-19 |
1999-03-30 |
Watson; Jerry Wade |
Camera mount for firearms
|
GB9726398D0
(en)
|
1997-12-12 |
1998-02-11 |
Isis Innovation |
Polypeptide and coding sequences
|
ES2333071T5
(es)
|
1998-01-14 |
2015-08-17 |
Novartis Vaccines And Diagnostics S.R.L. |
Antígenos de Neisseria meningitidis
|
ES2294629T3
(es)
|
1998-05-01 |
2008-04-01 |
Novartis Vaccines And Diagnostics, Inc. |
Antigenos de neisseria y composiciones.
|
US20070026021A1
(en)
*
|
1998-05-01 |
2007-02-01 |
Chiron S.R.I. |
Neisseria meningitidis antigens and compositions
|
AU1202200A
(en)
|
1998-10-09 |
2000-05-01 |
Chiron Corporation |
Neisseria genomic sequences and methods of their use
|
US6146902A
(en)
|
1998-12-29 |
2000-11-14 |
Aventis Pasteur, Inc. |
Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
|
US6425697B1
(en)
|
1999-03-17 |
2002-07-30 |
Jeff C. Potts |
Universal camera mounting assembly
|
PT1228217E
(pt)
|
1999-04-30 |
2013-01-28 |
Novartis Vaccines & Diagnostic |
Antígenos de neisseria conservados
|
ES2323845T3
(es)
|
1999-04-30 |
2009-07-27 |
Novartis Vaccines And Diagnostics, Inc. |
Secuencias genomicas de neisseria y procedimientos de uso.
|
NZ536676A
(en)
|
1999-05-19 |
2006-11-30 |
Chiron S |
Combination neisserial compositions comprising amino acid sequences
|
US6192614B1
(en)
|
1999-07-23 |
2001-02-27 |
Daniel Cliburn |
Video mounting system for firearm
|
GB9918319D0
(en)
|
1999-08-03 |
1999-10-06 |
Smithkline Beecham Biolog |
Vaccine composition
|
ES2539951T3
(es)
|
1999-10-29 |
2015-07-07 |
Novartis Vaccines And Diagnositics S.R.L. |
Péptidos antigénicos de Neisseria
|
GB9928196D0
(en)
|
1999-11-29 |
2000-01-26 |
Chiron Spa |
Combinations of B, C and other antigens
|
EP1741784B1
(en)
*
|
1999-11-29 |
2010-03-10 |
Novartis Vaccines and Diagnostics S.r.l. |
85kDa neisserial antigen
|
EP2281571A3
(en)
*
|
2000-01-17 |
2012-04-25 |
Novartis Vaccines and Diagnostics S.r.l. |
Outer membrane vesicle (omv) vaccine comprising n. meningitidids serogroup b outer membrane proteins
|
CN102417537A
(zh)
|
2000-01-25 |
2012-04-18 |
昆士兰大学 |
包含脑膜炎奈瑟氏球菌表面抗原NhhA的保守区域的蛋白质
|
AU3948801A
(en)
|
2000-02-28 |
2001-09-12 |
Chiron Spa |
Heterologous expression of neisserial proteins
|
WO2002009643A2
(en)
|
2000-07-27 |
2002-02-07 |
Children's Hospital & Research Center At Oakland |
Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
|
GB0103170D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
ES2544979T3
(es)
|
2001-01-23 |
2015-09-07 |
Sanofi Pasteur Inc. |
Vacuna de conjugado de polisacárido-CRM197 meningocócica tri- o tetravalente
|
GB0103171D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
RU2323002C2
(ru)
*
|
2001-07-26 |
2008-04-27 |
Чирон Срл. |
Вакцины, содержащие алюминиевые адъюванты и гистидин
|
GB0118249D0
(en)
*
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
DE60236596D1
(de)
*
|
2001-07-27 |
2010-07-15 |
Novartis Vaccines & Diagnostic |
Antikörper gegen das meningokokken adhäsin app
|
AR045702A1
(es)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
GB0220197D0
(en)
|
2002-08-30 |
2002-10-09 |
Univ Utrecht |
Refolding method
|
CA2493977A1
(en)
|
2002-08-02 |
2004-02-19 |
Glaxosmithkline Biologicals Sa |
Vaccine composition comprising lipooligosaccharide with reduced phase variability
|
US7785608B2
(en)
*
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
EP2353608B1
(en)
*
|
2002-10-11 |
2019-12-18 |
Novartis Vaccines and Diagnostics S.r.l. |
Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
US20070148729A1
(en)
|
2003-01-15 |
2007-06-28 |
Farley John E |
Methods for increasing neisseria protein expression and compositions thereof
|
PT1587537E
(pt)
|
2003-01-30 |
2012-05-30 |
Novartis Ag |
Vacinas injetáveis contra múltiplos serogrupos meningocócicos
|
WO2004094596A2
(en)
|
2003-04-16 |
2004-11-04 |
Wyeth Holdings Corporation |
Novel immunogenic compositions for the prevention and treatment of meningococcal disease
|
US7731967B2
(en)
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
GB0315021D0
(en)
*
|
2003-06-26 |
2003-07-30 |
Chiron Srl |
Immunogenic gonococcal compositions
|
EP2277538A1
(en)
*
|
2003-10-02 |
2011-01-26 |
Novartis Vaccines and Diagnostics S.r.l. |
Combined meningitis vaccines
|
GB0408977D0
(en)
*
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Immunising against meningococcal serogroup Y using proteins
|
GB0409748D0
(en)
|
2004-04-30 |
2004-06-09 |
Chiron Srl |
Lactoferrin cleavage
|
GB0419408D0
(en)
|
2004-09-01 |
2004-10-06 |
Chiron Srl |
741 chimeric polypeptides
|
GB0419627D0
(en)
*
|
2004-09-03 |
2004-10-06 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
HUE033196T2
(en)
|
2005-01-27 |
2017-11-28 |
Children's Hospital & Res Center At Oakland |
GNA1870-based vesicle vaccines for broad-spectrum protection against diseases caused by Neisseria meningitidis
|
EP2201961B1
(en)
*
|
2005-06-27 |
2018-01-24 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
GB0524066D0
(en)
*
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
RU2450019C2
(ru)
*
|
2006-06-29 |
2012-05-10 |
Новартис Аг |
Полипептиды из neisseria meningitidis
|
US7491517B2
(en)
*
|
2006-07-19 |
2009-02-17 |
Jeeri R Reddy |
Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
WO2008125985A2
(en)
|
2007-04-11 |
2008-10-23 |
Novartis Ag |
Blocking interaction between pathogen factors and factor h to inhibit hemorrhagic syndromes
|
NZ581367A
(en)
|
2007-06-04 |
2012-05-25 |
Novartis Ag |
Formulation of meningitis vaccines containing haemophilus influenzae and neisseria meningitidis
|
AU2009215364B2
(en)
|
2008-02-21 |
2014-09-18 |
Glaxosmithkline Biologicals S.A. |
Meningococcal fHBP polypeptides
|
EP2265640B1
(en)
|
2008-03-10 |
2015-11-04 |
Children's Hospital & Research Center at Oakland |
Chimeric factor h binding proteins (fhbp) containing a heterologous b domain and methods of use
|
EP2297578A2
(en)
*
|
2008-05-19 |
2011-03-23 |
Novartis AG |
Vaccine assays
|
WO2010028096A2
(en)
|
2008-09-03 |
2010-03-11 |
Children's Hospital & Research Center At Oakland |
Peptides presenting an epitope of an a domain of factor h binding protein and methods of use
|
IT1394288B1
(it)
|
2008-09-12 |
2012-06-06 |
Novartis Vaccines & Diagnostic |
Immunogeni di proteine che legano il fattore h.
|
GB0819633D0
(en)
|
2008-10-25 |
2008-12-03 |
Isis Innovation |
Composition
|
EP2411048B1
(en)
|
2009-03-24 |
2020-05-06 |
GlaxoSmithKline Biologicals SA |
Adjuvanting meningococcal factor h binding protein
|
EP2544714A1
(en)
|
2010-03-10 |
2013-01-16 |
GlaxoSmithKline Biologicals S.A. |
Vaccine composition
|
TR201802933T4
(tr)
|
2010-03-30 |
2018-03-21 |
Childrens Hospital & Res Center At Oakland |
Özellikleri değiştirilmiş faktör h bağlama proteinleri (fhbp) ve bunların kullanım yöntemi.
|
ES2759484T3
(es)
|
2010-09-10 |
2020-05-11 |
Glaxosmithkline Biologicals Sa |
Meningococo que sobreexpresa NadA y/o NHBA y vesículas de la membrana externa derivadas del mismo
|